US Stock MarketDetailed Quotes
DVAX Dynavax Technologies
- 12.420
- +0.060+0.49%
Close Nov 22 16:00 ET
- 12.500
- +0.080+0.64%
Post 20:01 ET
1.63BMarket Cap82.80P/E (TTM)
12.580High12.315Low902.69KVolume12.320Open12.360Pre Close11.23MTurnover0.86%Turnover RatioLossP/E (Static)131.45MShares15.01052wk High2.40P/B1.30BFloat Cap9.74052wk Low--Dividend TTM104.87MShs Float106.600Historical High--Div YieldTTM2.14%Amplitude1.500Historical Low12.440Avg Price1Lot Size
About Dynavax Technologies Company
Dynavax Technologies Corp. operates as a biopharmaceutical company, which engages in the discovery, development, and commercialization of novel vaccines and immuno-oncology therapeutics. Its product includes HEPLISAV-B, which prevents infection caused by all known subtypes of hepatitis B virus in adults 18 years of age and older. The company was founded by Lawrence M. Lichtenstein, Dennis A. Carson, and Eyal Raz on August 29, 1996 and is headquartered in Emeryville, CA.
Company Profile
SymbolDVAX
Company NameDynavax Technologies
Listing DateFeb 19, 2004
Issue Price7.50
Founded1996
CEOMr. Ryan Spencer
MarketNASDAQ
Employees408
Fiscal Year Ends12-31
Address2100 Powell Street,Suite 900
CityEmeryville
ProvinceCalifornia
CountryUnited States of America
Zip Code94608
Phone1-510-848-5100
Websitehttp://www.dynavax.com
Company Executives
- Name
- Position
- Salary
- Ryan Spencer
- Chief Executive Officer and Director
- 5.59M
- David Novack
- President and Chief Operating Officer
- 2.78M
- Dr. Robert Janssen, M.D.
- Chief Medical Officer and Senior Vice President, Clinical Development, Medical and Regulatory Affairs
- 1.71M
- Kelly MacDonald
- Senior Vice President and Chief Financial Officer
- 1.79M
- Justin Burgess
- Controller and Chief Accounting Officer
- --
- John L. Slebir
- Senior Vice President and General Counsel
- --
- Scott D. Myers
- Chairman of the Board
- 323.73K
- Brent MacGregor
- Independent Director
- 278.73K
- Dr. Francis R. Cano, PhD
- Independent Director
- 278.73K
- Julie M. Eastland
- Independent Director
- 293.73K
- Elaine D. Sun
- Independent Director
- 278.73K
- Dr. Daniel L. Kisner, M.D.
- Independent Director
- 290.73K
- Dr. Peter R. Paradiso, PhD
- Independent Director
- 277.73K
- Peggy V. Phillips
- Independent Director
- 298.73K
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data